ALYSSA MILLIRON: Open Payments
NPI 1033640099 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 57 payments from 15 companies in 2025. Trend: 2023 $537 · 2024 $1,453 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $218 |
| Daiichi Sankyo Inc. | 15 | $142 |
| Novo Nordisk Inc | 4 | $117 |
| PFIZER INC. | 3 | $95 |
| Lilly USA, LLC | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| ALK-Abello, Inc | 2 | $42 |
| Exact Sciences Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: INJECTAFER, PREVNAR 20, Wegovy, QULIPTA, CREON, CAPLYTA, MOUNJARO, SPRAVATO.
Industry payments across CA — which companies pay providers there.
